UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
UroGen Pharma Ltd. reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
UroGen Pharma Ltd. reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, five executives at UroGen Pharma Ltd. received on average a compensation package of $5.9M, a 80% increase compared to previous year.
Average pay of disclosed executives at UroGen Pharma Ltd.
Elizabeth Barrett, Chief Executive Officer, received $26M in total. 58% of Barrett's compensation, or $15M, was in stock awards. Barrett also received $300K in bonus, $840K in non-equity incentive plan, $9M in option awards, $695K in salary, as well as $4.1K in other compensation.
For fiscal year 2019, the median employee pay was $223,867 at UroGen Pharma Ltd.. Therefore, the ratio of Elizabeth Barrett's pay to the median employee pay was 116 to one.
Peter P. Pfreundschuh, Chief Financial Officer, received a compensation package of $1.3M, which decreased by 46% compared to previous year. 32% of the compensation package, or $436K, was in option awards.
Stephen Mullennix, Chief Operating Officer, earned $1.3M in 2019, a 69% decrease compared to previous year.
Mark Schoenberg, Chief Medical Officer, received $801K in 2019, which increases by 167% compared to 2018.
Ron Bentsur, Chief Executive Officer, earned $8.1K in 2019, a 100% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.